ICBMT 2024. ICBMT 2024. THE 8th INTERNATIONAL CONGRESS OF BMT 2024. THE 29th ANNUAL CONGRESS OF KSBMT.

Moving Forward into the New Era of HSCT and Cellular Therapy

SEPTEMBER 26(Thu) - 28(Sat), 2024. BEXCO, BUSAN, KOREA
HOME

Abstract Submission

The ICBMT 2024 Organizing Committee cordially invites you to submit abstracts. The Scientific Committee will review the submitted abstracts, and those accepted will be presented either as Oral or Poster presentations.

Please read the guidelines carefully before submitting your abstract.

Important Dates

  • Deadline for Abstract Submission July 5, 2024
  • Notification of Abstract Acceptance Early August, 2024
  • Deadline for Presenter Registration August 16,2024
Abstract Submission

Steps for Submission

  • STEP 1

    Sign-up and Login If you are already signed-up on this website, you can use the account for your abstract submission.

  • STEP 2

    Submit Your Abstract Fill out the author and abstract information and click the
    "Save and Next" button.

  • STEP 3

    Confirmation Letter After your submission, a confirmation letter will be sent to you via E-mail.

  • STEP 4

    My Page You can review and modify your submitted abstracts on
    "MY PAGE" until the submission deadline

  • STEP 5

    Acceptance Notification An acceptance notification
    will be sent to you via E-mail.

Abstract Topics

Abstract Topics
Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Bone Marrow Failure
  • Diagnosis and prognostication
  • Treatment including induction treatment, stem cell transplantation and salvage treatment
  • Clinical trials including novel drugs
  • Diagnosis and prognostication
  • Treatment including induction treatment, stem cell transplantation and salvage treatment
  • Clinical trials including novel drugs
  • Aplastic anemia
  • Myelodysplastic syndrome
  • Other disorders
Cellular & Gene Therapy Blood and Marrow Collection and Processing Infectious Complications
  • In vitro and pre-clinical study
  • Clinical trials with cell therapy
  • Gene therapy
  • Hematopoietic stem cell collection
  • Mobilization and processing
  • Growth factors and cytokines
  • Acute infectious complications related with stem cell transplantation
  • Late infectious complications from transplant survivors
  • Vaccination and prevention of infection
Lymphoma Post-transplant Complications (Non-infectious) Myeloma
  • Genomics of lymphoma
  • Induction and salvage treatment for lymphoma
  • Autologous and allogeneic stem cell transplantation for lymphoma
  • Post-transplantation failure management
  • Acute and chronic GVHD
  • Other acute complications
  • Late complications
  • Long-term survivor management
  • Genomics of myeloma
  • Induction and salvage treatment for myeloma
  • Autologous and allogeneic stem cell transplantation for myeloma
  • Post-transplantation failure management
Nursing/Allied Health Pediatric Hematology/Oncology Transplantation Specific Topics
  • Quality of life
  • Stem cell donation
  • Nursing care for stem cell transplantation
  • Nutritional support
  • Education of post-transplant survivors
  • Pediatric hematologic malignancy
  • Pediatric nonmalignant disease
  • Pediatric oncology
  • Conditioning regimens
  • Transplantation protocols
  • Cord blood transplantation
  • Haploidentical transplantation
  • Donor selection process
Stem Cell Biology Others
  • Cancer stem cells
  • Hematopoietic stem cells
  • Others

Abstract Submission Guidelines

Theses guidelines are for general participants, not invited speakers.

  • All abstracts must be submitted online via the ICBMT 2024 website. Abstracts submitted by E-mail, fax or post will NOT be accepted.
  • Abstracts must be written in clear English and submitted prior to July 5, 2024.
  • The abstract should be objective and concise, including key information in its four sections: Background/Aim, Methods, Results, Conclusions.
  • No further proofreading or corrections will be allowed after the submission deadline. It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.
  • Authors have the option of choosing their presentation type (oral or poster presentation). However, the scientific committee will make the final decision on presentation type after review of the abstracts.
  • The presenting author must register for ICBMT 2024 during the early registration period. If the presenting author does not complete registration with full payment by August 16, 2024, the abstract will be withdrawn.
Abstract Topics
Title Capitalize the first letter of each word.
Limit of 30 words
Author Information Name: Write first and family name(s) in full.
Affiliation should be structured as follows: Department, Institution, Country.
Degrees or titles such as MD after an author’s name must be deleted.
Abstract Body Structured chronologically into four sections: Background/Aim, Methods, Results, Conclusions
Limit of 300 words
Keywords No more than 6 keywords of which the first word begins with a capital letter
Tables and Images The total number of tables/graphs/images should not exceed two

Notification of Acceptance

  • All submitted abstracts will be reviewed by the Scientific Committee according to reviewing procedures.
  • Notifications of acceptance will be sent by e-mail to corresponding and presenting authors From Early August, 2024.

Withdrawal of Abstracts

  • If the presenting author of an accepted abstract does not register by August 16, 2024, the abstract will be automatically withdrawn from the final program.
  • If you must withdraw an abstract, please notify the secretariat (icbmt@icbmt.or.kr) in writing as soon as possible.